New meta-analysis provides a comprehensive view of real-world data and furthers understanding of Entyvio as an important treatment option for patients with ulcerative colitis or Crohn's disease ...

Entyvio (generic name vedolizumab) is now available as a self-administered injection for cases of moderately-to-severely ...

One of the advantages of some of the infusion medicines is that there's a nurse monitoring the appointments. And if patients don't come for their appointments, then they get a call and a reminder.

Ulcerative colitis (UC) and Crohn’s disease (CD) are two of the most common forms of inflammatory bowel disease (IBD). 2 Both UC and CD are chronic, relapsing, remitting, inflammatory conditions of ...

During the 12-week induction study, participants were randomly assigned to receive guselkumab 200mg (n=421) or placebo (n=280) by intravenous (IV) infusion at week 0, week 4, and week 8.

The FDA approved the Stelara biosimilar, Selarsdi, as a 130 mg/26 mL single-dose IV infusion for adult patients with Crohn’s disease and ulcerative colitis, Alvotech and Teva Pharmaceuticals ...